How Lifestyle Coaching Styles Affect Patient Participation and Weight Loss in UK Non-Diabetic Patients Using a Semaglutide Digital Weight Loss Program

Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Bellberry Human Ethics Committee issued approval 2023-05-563-A-3, dated November 22, 2023. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: Louis Talay, Matt Vickers, Leif Lagesen, Nicole Liu declare(s) employment from Eucalyptus. LT, MV, L.L and N.L are paid a salary by Eucalyptus (Juniper parent company) throughout the study period. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.